Antitrust and Consumer Protection
Competition: Winter 2017-18, Vol. 27, No. 1
Content
- Antitrust's Hidden Hook In Drug Price Increases
- Causation Principles In Pharmaceutical Antitrust Litigation
- Certificates of Public Advantage: Bypassing the Ftc In Healthcare Mergers?
- Digital Health Privacy: Old Laws Meet New Technologies
- Editor's Note
- Empirical Evidence of Drug Companies Using Citizen Petitions To Hold Off Competition
- Masthead
- Rethinking Healthcare Data Breach Litigation
- The Efficiencies Defenestration: Are Regulators Throwing Valid Healthcare Efficiencies Out the Window?
- The Proximate Cause Requirement In Private Reverse Payment Antitrust Litigation
- Uncertainty and Scientific Complexity: An Introduction To Economic Forces That Drive Current Debates In Healthcare Antitrust
- What Past Agency Actions Say About Complexity In Merger Remedies, With An Application To Generic Drug Divestitures
- Where Art Thou, Efficiencies? the Uncertain Role of Efficiencies In Merger Review
- Chair's Column
CHAIR’S COLUMN
Jill M. Manning
Steyer Lowenthal Boodrookas Alvarez & Smith LLP
San Francisco, CA
The Antitrust, Unfair Competition & Privacy Law Section of the California Lawyers Association is pleased to provide you with the February 2018 edition of its journal, Competition, the first edition focusing exclusively on competition issues in the healthcare and pharmaceutical industries. Special thanks to Editor-in-Chief, Anna Fabish, and her team of terrific authors and editors for their hard work in putting this issue together.